£1.97m
+39%vs Mar 2025Active13959878Private limited companyLondon
LUCENT BIOPHARMA LTD
A84/100From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
01
Summary
LUCENT BIOPHARMA LTD is an active private limited company (company number 13959878) incorporated on 7 March 2022, registered in London. Its registered activity is other professional, scientific and technical activities n.e.c. (SIC 74909). Latest small accounts cover the period ending 31 March 2026, showing net assets of £1.97m and cash of £223k, with 8 employees on average. Net assets rose 39% on the prior period (£1.42m).
Peer position · net assets
By net assets it sits in the top quarter of 7,601 comparable companies in London (median £3,258, upper quartile £44k).
02
Key dates
- Incorporated
- 7 March 20224 yrs ago
- Next accounts due
- 31 December 2027in 435 days
- Confirmation statement due
- 21 March 2027in 150 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
04
Financials
£223k
+136%vs Mar 2025Not reported
8
+100%vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £1.97m | £223k | £442k | £446k | — | — | 8 |
| 31 March 2025 | £1.42m | £94k | £480k | £511k | — | — | 4 |
Current ratio5.26Comfortable
Cash per employee£28kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
84 / 100 · grade A
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £1,973,829 at 2026-03-31 |
| +8 | Net assets growing+39.3% vs prior period |
| +8 | Comfortable liquidityCurrent ratio 5.26 |
| +4 | Cash reservesCash £222,607 |
| +4 | Past first filingsIncorporated 2022-03-07 |
| 84 | Score, grade A |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Matthew Leigh Goodman
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
- Ms Eleanor Harrison
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Next accounts duein 435 days
- Confirmation statement duein 150 days
- Accounts period endNet assets £1.97m · small accounts
- Accounts period endNet assets £1.42m · small accounts
- Incorporated
08
Similar companies in London
09
Reminders for LUCENT BIOPHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.